The Technical Accelerator Award supports research and development of therapeutics, vaccines, and diagnostic technologies to prevent and alleviate the infection, progression, and spread of endemic or emerging infectious diseases in low- and middle-income countries. The amount of support is KRW 500 million per project, and at least one Korean entity must be included.

For more detailed information, please refer to the attached document.